MUMBAI, India, July 4, 2018 /PRNewswire/ --
Ideal Cures, an Indian company headquartered in Mumbai,
India, launched two new ready-to-use film coating products INSTACOAT QD and INSTACOAT T2F, at the 2nd Formulation and Drug Delivery Conclave (FDD), held on 15th-16th June 2018, at Hyderabad,
(Logo: https://mma.prnewswire.com/media/714539/Ideal_Cures_Logo.jpg )
INSTACOAT QD, quick disintegrating film coating product is revolutionary for pharmaceutical applications which provides fast disintegration of film within 3-30 seconds.
INSTACOAT T2F is a brilliant ready-to-use coating product by Ideal Cures that is completely free from Talc and TiO2. This product was developed because there have been many speculations, questions and concerns about talc and titanium dioxide as being carcinogenic. Hence, their use is discouraged in Europe and US.
Mr. Suresh Pareek, Managing Director of Ideal Cures Pvt. Ltd., who is also one of the inventors, said, "Ideal Cures is driven by its vision to provide the best solutions to the industry by continuously developing new and innovative products. We aimed to add another milestone to our mission of assisting the pharma industry with its need for better drug delivery systems and regulatory compliances with these two products."
About Ideal Cures:
Ideal Cures (IC) is amongst India's leading manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. IC provides tailor-made solutions and products for the pharmaceutical and allied industries, through a network of customers and partners across more than 40 countries around the world. It is the first film coating company to have all its cGMP compliant manufacturing plants EXCiPACT™ certified. IC's latest manufacturing facility in Sikkim will be certified in due course. An ISO 9001:2015 certified company with a US DMF for all its manufacturing facilities; IC is one of the most innovative film-coating companies.
For a comprehensive, time-saving tablet coating experience, Talk to Us!
Join us on LinkedIn for quick updates on our new product launches and upcoming events!
Media Contact: Saryu Pareek Gupta Vice President - Corporate Communications Ideal Cures Pvt. Ltd., Mumbai, India +91-2242688700 Email: firstname.lastname@example.org Web - http://www.idealcures.com India HO and R&D centre A-223 to 229, Virwani Industrial estate Off western express highway Goregaon (East), Mumbai - 4000063 India
SOURCE Ideal Cures Private Limited
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All